
Peripheral Intravascular Lithotripsy Market Report 2026
Global Outlook – By Device Component (Intravascular Lithotripsy (IVL) Catheters, Generator or Console Systems, Accessories or Connectors), By Indication (Peripheral Artery Disease (PAD), Dialysis Access Lesions, Coronary, Other Indications), By Application (Femoral-Popliteal, Iliac Artery, Infrapopliteal), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Vascular Clinics) – Market Size, Trends, Strategies, and Forecast to 2035
Peripheral Intravascular Lithotripsy Market Overview
• Peripheral Intravascular Lithotripsy market size has reached to $1.29 billion in 2025 • Expected to grow to $2.39 billion in 2030 at a compound annual growth rate (CAGR) of 13.1% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases Fueling The Growth Of The Market Due To Aging Population And Increasing Arterial Calcification • Market Trend: Innovative Forward-Facing Catheter Breaks Through Complex Calcified Artery Blockages • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Peripheral Intravascular Lithotripsy Market?
Peripheral intravascular lithotripsy is a minimally invasive medical procedure used to treat calcified plaque buildup in peripheral arteries, especially in the legs. It uses sonic pressure waves delivered through a specialized balloon catheter to fracture hardened calcium within the artery walls. It helps to improve blood flow by modifying severe arterial calcification, allowing safer and more effective balloon angioplasty or stent placement. The main device components of peripheral intravascular lithotripsy include intravascular lithotripsy (IVL) catheters, generator or console systems, and accessories or connectors. IVL catheters are specialized devices designed to deliver acoustic pressure waves to calcified vascular lesions, facilitating safe plaque modification and vessel expansion. They are applied for indications including peripheral artery disease (PAD), dialysis access lesions, coronary applications, and other indications. They find application in femoral-popliteal, iliac artery, and infrapopliteal procedures, serving end users including hospitals, ambulatory surgical centers, and specialty vascular clinics.
What Is The Peripheral Intravascular Lithotripsy Market Size and Share 2026?
The peripheral intravascular lithotripsy market size has grown rapidly in recent years. It will grow from $1.29 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, adoption of traditional angioplasty techniques, increasing geriatric population, demand for safer vascular interventions, growth of hospital cardiovascular departments.What Is The Peripheral Intravascular Lithotripsy Market Growth Forecast?
The peripheral intravascular lithotripsy market size is expected to see rapid growth in the next few years. It will grow to $2.39 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to adoption of intravascular lithotripsy devices, integration with advanced imaging modalities, demand for precision vascular therapies, expansion of ambulatory surgical centers, investment in next-generation IVL catheters. Major trends in the forecast period include minimally invasive treatment adoption, advanced catheter technologies, integration with imaging systems, personalized pad management, real-time procedure monitoring.Global Peripheral Intravascular Lithotripsy Market Segmentation
1) By Device Component: Intravascular Lithotripsy (IVL) Catheters, Generator or Console Systems, Accessories or Connectors 2) By Indication: Peripheral Artery Disease (PAD), Dialysis Access Lesions, Coronary, Other Indications 3) By Application: Femoral-Popliteal, Iliac Artery, Infrapopliteal 4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Vascular Clinics Subsegments: 1) By Intravascular Lithotripsy (IVL) Catheters: Peripheral Catheters, Coronary Catheters, Forward Facing Catheters, Specialty Catheters 2) By Generator or Console Systems: Portable Generators, Stationary Generators, Integrated Console Systems, Battery Operated Systems 3) By Accessories or Connectors: Connector Cables, Adapters, Guidewires, Catheter TipsWhat Is The Driver Of The Peripheral Intravascular Lithotripsy Market?
The rising prevalence of cardiovascular diseases is expected to propel the growth of the peripheral intravascular lithotripsy market going forward. Cardiovascular diseases are conditions affecting the heart and blood vessels, including coronary heart disease, stroke, heart failure, and arrhythmias. The prevalence of cardiovascular diseases is growing due to aging populations, as advancing age significantly increases the risk of developing heart and vascular conditions, particularly among those over 65 years. Peripheral intravascular lithotripsy helps cardiovascular diseases by safely breaking down calcified arterial plaques, improving vessel compliance, and enhancing blood flow to reduce the risk of ischemic complications. For instance, in February 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths from cardiovascular disease in blackpool increased from 178 in 2022 to 185 in 2023. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the peripheral intravascular lithotripsy industry.Key Players In The Global Peripheral Intravascular Lithotripsy Market
Major companies operating in the peripheral intravascular lithotripsy market are Johnson & Johnson, Boston Scientific Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology Co Ltd., Biosensors International Group Ltd., Amplitude Vascular Systems Inc., AVS Pulse Inc., Genesis MedTech Pte Ltd, Jiangsu Pupeng Medical Technology Co Ltd., Elixir Medical Corporation, Spectrumedics International, FastWave Medical Inc., Cardiovascular Systems Inc., Suzhou Zhonghui Medical Technology Co Ltd.Global Peripheral Intravascular Lithotripsy Market Trends and Insights
Major companies operating in the peripheral intravascular lithotripsy market are focusing on developing advanced products, such as larger-diameter catheters, to treat complex calcification in larger peripheral vessels and improve patient outcomes. Larger-diameter IVL catheters refer to advanced devices designed to deliver sonic pressure waves to modify calcified plaque in arteries like the iliac and common femoral, which are otherwise difficult to treat with standard techniques. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched the Shockwave Javelin Peripheral IVL Catheter following clearance by the U.S. Food and Drug Administration (FDA). It is an innovative forward IVL platform designed to modify calcium and cross extremely narrowed vessels that are challenging for conventional devices to treat. The Javelin catheter features a 150 cm working length and a single distal emitter capable of generating up to 120 shockwave pulses that create a spherical energy field extending beyond the catheter tip, delivering lithotripsy closer to the calcium compared with balloon-based IVL systems. It enhances the ability of clinicians to treat subtotal occlusions and complex calcified lesions across the peripheral anatomy, potentially improving procedural success and patient outcomes.What Are Latest Mergers And Acquisitions In The Peripheral Intravascular Lithotripsy Market?
In April 2024, Johnson & Johnson, a US-based healthcare company, acquired Shockwave Medical Inc. for $13.1 billion. With this acquisition, Johnson & Johnson aims to expand and strengthen its position in the high-growth cardiovascular intervention market by adding Shockwave’s innovative intravascular lithotripsy (IVL) technology to its MedTech portfolio. Shockwave Medical Inc. is a US-based company that provides peripheral intravascular lithotripsy (IVL) systems to treat severely calcified peripheral arterial disease above and below the knee.Regional Insights
North America was the largest region in the peripheral intravascular lithotripsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Peripheral Intravascular Lithotripsy Market?
The peripheral intravascular lithotripsy market consists of revenues earned by entities by providing services such as shockwave therapy procedures, catheter-based device deployment, clinical consultation and patient assessment, post-procedural monitoring and follow-up care, and training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral intravascular lithotripsy market also includes sales of portable generator systems, connector cables and interface accessories, sterile procedure packs, and imaging and navigation support devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data And Analysis Are Included In The Peripheral Intravascular Lithotripsy Market Report 2026?
The peripheral intravascular lithotripsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral intravascular lithotripsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Peripheral Intravascular Lithotripsy Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.46 billion |
| Revenue Forecast In 2035 | $2.39 billion |
| Growth Rate | CAGR of 12.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Device Component, Indication, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Johnson & Johnson, Boston Scientific Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology Co Ltd., Biosensors International Group Ltd., Amplitude Vascular Systems Inc., AVS Pulse Inc., Genesis MedTech Pte Ltd, Jiangsu Pupeng Medical Technology Co Ltd., Elixir Medical Corporation, Spectrumedics International, FastWave Medical Inc., Cardiovascular Systems Inc., Suzhou Zhonghui Medical Technology Co Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
